Skip to main navigation
Investor Relations
Press ReleasesCompany StatementsMedia ContactEmail Alerts
Events & PresentationsFinancialsStock InformationGovernanceResources
Compliance & Transparency
Our LocationsMedical Information
magnifying glass icon
Incyte Home
Main Nav
  • Our Company
  • What We Do
  • Culture & Careers
  • Patient Resources
  • HCP Resources
  • Our Stories
  • Responsibility
  • Our Company
    • Our Leadership
  • What We Do
    • Portfolio
    • Hematology and Oncology
      • Approved Therapies
      • HCP Resources
    • Inflammation and Autoimmunity
      • Approved Therapies
      • HCP Resources
    • Partnerships
  • Culture & Careers
    • Open Positions
    • Incyte Involved
    • Inclusion
  • Patient Resources
  • HCP Resources
  • Our Stories
  • Responsibility
    • Compliance & Transparency
Main Nav
  • magnifying glass icon
  • Our Company
    • magnifying glass icon
    • Our Leadership
  • What We Do
    • magnifying glass icon
    • Portfolio
    • Hematology and Oncology
    • Inflammation and Autoimmunity
    • Partnerships
  • Culture & Careers
    • magnifying glass icon
    • Open Positions
    • Incyte Involved
    • Inclusion
  • Patient Resources
  • HCP Resources
  • Our Stories
  • News
    • magnifying glass icon
    • Company Statements
    • Media Contact
    • Email Alerts
  • Investors
    • magnifying glass icon
    • Events & Presentations
    • Financials
    • Stock Information
    • Governance
    • Resources
  • Responsibility
    • magnifying glass icon
    • Compliance & Transparency
  • Contact Us
    • magnifying glass icon
    • Our Locations
    • Medical Information
  • United States
Home  >  Investors  >  Press Releases

Press Releases

Incyte International Locations

NORTH AMERICA— HEADQUARTERS

DENMARK

ITALY

SPAIN

UNITED KINGDOM

EUROPE— HEADQUARTERS

FINLAND

JAPAN

SWEDEN

AUSTRIA

FRANCE

THE NETHERLANDS

SWITZERLAND

CANADA

GERMANY

NORWAY

PORTUGAL

Close

The information contained in press releases should be considered accurate only as of the date of the press release. We disclaim any obligation to supplement or update the information in these press releases.

March 28, 2026
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
March 25, 2026
Incyte Announces Executive Leadership Appointments
March 20, 2026
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting
March 6, 2026
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
February 17, 2026
Incyte to Present at Upcoming Investor Conferences
February 10, 2026
Incyte Reports Fourth Quarter and Full Year 2025 Financial Results
January 30, 2026
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
January 27, 2026
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results
January 5, 2026
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a First-line Treatment for Diffuse Large B-Cell Lymphoma

For Media Inquiries

media@incyte.com

For Investor Relations

ir@incyte.com 

Incyte Home
  • LinkedIn Icon
  • Twitter Icon
  • Instagram Icon
  • Facebook Icon
  • Youtube Icon
  • Our Company
  • Our Leadership
  • What We Do
  • Portfolio
  • Hematology and Oncology
  • Inflammation and Autoimmunity
  • Partnerships
  • Culture & Careers
  • Open Positions
  • Incyte Involved
  • Inclusion
  • Patient Resources
  • HCP Resources
  • Our Stories
  • News
  • Press Releases
  • Company Statements
  • Media Contact
  • Email Alerts
  • Investors
  • Events & Presentations
  • Financials
  • Stock Information
  • Governance
  • Resources
  • Responsibility
  • Compliance & Transparency
  • Contact Us
  • Our Locations
  • Medical Information
  • Legal Notice
  • Suppliers
  • Site Map
  • Privacy Policy
  • Cookie Policy
  • Consumer Health Data Privacy Policy
© 2012-2026 Incyte.